Topical lidocaine 2 % is formulated for skin use. Applying it to mucous membranes can increase systemic absorption and is not recommended unless a clinician has specifically instructed otherwise.
Most users experience numbness for 1-2 hours after a single dose. The duration can vary based on the thickness of the skin and the amount applied.
The tube formulation is generally not advised for children under 2 years. For older children, a healthcare professional should assess the appropriate dose and frequency.
Topical lidocaine is not a prohibited substance in standard drug-testing panels. However, very high systemic levels could theoretically be detected; this is unlikely with normal use.
The tube typically bears the brand name “Xylocaine” in bold lettering, along with the concentration “2 %” and the MHRA licence number. Appearance may vary by manufacturer.
Lidocaine is classified as pregnancy category B3 in the UK, indicating limited data. It should only be used if the benefit outweighs potential risk, and after consulting a healthcare professional.
Tolerance to topical lidocaine is uncommon. However, repeated excessive application can increase systemic exposure and raise the risk of toxicity.
Do not flush the tube down the toilet. Return it to a pharmacy’s medicine-take-back program or follow local household-hazard disposal guidelines.
Avoid using other topical anesthetics (e.g., benzocaine, prilocaine) on the same area, as this may increase total lidocaine absorption. If you need additional skin care, choose non-medicated moisturisers.
After opening, the product remains stable for up to 12 months if stored correctly (sealed, at room temperature, away from light). Check the expiry date printed on the label.
Xylocaine is a brand name for a medication whose active ingredient is lidocaine. It belongs to the pain-relief therapeutic class and is supplied as a 2 % lidocaine solution in a tube for topical application. In the United Kingdom, Xylocaine is a prescription-only product (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Lidocaine is a local anesthetic. It works by blocking voltage-gated sodium channels on nerve membranes. When these channels are inhibited, the initiation and propagation of nerve impulses are prevented, producing a reversible loss of sensation in the area where the drug is applied.
Key points of the pharmacology:
Xylocaine 2 % topical gel is licensed in the UK for the temporary relief of minor pain, itching, or burning associated with minor skin irritations, such as:
It is not intended for deep or chronic pain conditions.
Evidence from peer-reviewed studies shows that lidocaine 2 % can be used off-label for short-term relief of post-herpetic neuralgia and procedural surface anesthesia (e.g., before minor skin suturing). These uses are not approved by the MHRA for Xylocaine tube, and any off-label use should be supervised by a qualified healthcare professional.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
Patients should inform their healthcare provider of all medicines, supplements, and herbal products before starting Xylocaine.
Dosing must be individualized by a healthcare provider; the above represents typical guidance for the 2 % topical formulation.
Routine laboratory monitoring is not required for short-term topical use. Patients should:
This article provides educational information about Xylocaine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
